EE386 Budget Impact of Durvalumab for the Treatment of Patients with Unresectable Stage III Non-Small Cell Lung Cancer in the Brazilian Private Healthcare System
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.652
https://www.valueinhealthjournal.com/article/S1098-3015(23)03782-8/fulltext
Title :
EE386 Budget Impact of Durvalumab for the Treatment of Patients with Unresectable Stage III Non-Small Cell Lung Cancer in the Brazilian Private Healthcare System
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03782-8&doi=10.1016/j.jval.2023.09.652
First page :
Section Title :
Open access? :
No
Section Order :
10141